ArticleMicroorganisms2026
Randomized, Double-Blind, Placebo-Controlled Clinical Trial Assessing the Efficacy of
Valentina Taverniti, Ines Martinez, Beatrice Tavazzani, Carlos Baeza-Martínez, Francisco López-Garcia, Carmen Carazo-Díaz, Juan Aguera Santos, Julio Villena, Susana Salva, María Pía Taranto and 3 more
Abstract read
In one paragraphArticle in Microorganisms, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors.
Valentina TavernitiSacco Srl, Alessandro Manzoni Street, 29/A, 22071 Cadorago, Italy.
Ines MartinezSacco Srl, Alessandro Manzoni Street, 29/A, 22071 Cadorago, Italy.
Beatrice TavazzaniSacco Srl, Alessandro Manzoni Street, 29/A, 22071 Cadorago, Italy.
Carlos Baeza-MartínezServicio de Neumología, Hospital Universitario de Elche, 03203 Alicante, Spain.ORCID 0000-0003-2814-413X Francisco López-GarciaServicio de Medicina Interna, Hospital Universitario de Elche, 03203 Alicante, Spain.
Carmen Carazo-DíazApplied Statistical Methods in Medical Research Group, Catholic University of Murcia (UCAM), 30107 Murcia, Spain.
Juan Aguera SantosHuman Microbiome Research Group, Universidad Católica San Antonio de Murcia (UCAM), 30107 Murcia, Spain.
Julio VillenaReference Center for Lactobacilli [CERELA-CONICET], Chacabuco 145, San Miguel de Tucumán T4000ILC, Argentina.ORCID 0000-0003-4941-4960 Susana SalvaReference Center for Lactobacilli [CERELA-CONICET], Chacabuco 145, San Miguel de Tucumán T4000ILC, Argentina.ORCID 0000-0001-9571-1259 María Pía TarantoReference Center for Lactobacilli [CERELA-CONICET], Chacabuco 145, San Miguel de Tucumán T4000ILC, Argentina.
Susana ÁlvarezReference Center for Lactobacilli [CERELA-CONICET], Chacabuco 145, San Miguel de Tucumán T4000ILC, Argentina.
Graciela FontReference Center for Lactobacilli [CERELA-CONICET], Chacabuco 145, San Miguel de Tucumán T4000ILC, Argentina.
Vicente Navarro-LópezHuman Microbiome Research Group, Universidad Católica San Antonio de Murcia (UCAM), 30107 Murcia, Spain.ORCID 0000-0003-3731-9827 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Upper respiratory tract infections (URTI) are highly prevalent worldwide. Although probiotics have shown potential in preventing URTI, evidence in healthy adults remains limited.
Indexed as
common coldgut-lung axisimmune systemprobioticsWURSS-21
Identifiers
PMID42354894
PMCPMC13303622
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390